Training

Register now

Virtual meeting

Via Zoom

Description

This training will provide waivered prescribers the skills needed to actually implement office-based addiction treatment into an ambulatory practice setting. Additionally, this talk will provide expert, concrete tips to facilitate the provision of care for patients with substance use disorders utilizing medications in their treatment. 

This training will be held via Zoom. Complete information on how to join via Zoom will be emailed to you the week of the training.

We will be offering 2.0 continuing education credits for NPs and 1.75 CMEs.

This is not a training to receive your buprenorphine waiver.

To request reasonable accommodations for a disability, please notify Tavi Hristova (tavita.hristova@bmc.org), in writing, at least two weeks prior to the conference.

Course Director: Dan Alford, MD, MPH

Intended audience

Prescribers who have recently obtained their X-waiver (or who are contemplating getting their waiver) and are looking to increase provision of care for patients with substance use disorder in an outpatient setting.

Speakers

Andrea Jodat, DNP, FNP-BC, CARN-AP

Andrea is a Nurse Practitioner and Clinical Educator for the OBAT TTA Program at Boston Medical Center with clinical interest and expertise in women's health, individuals experiencing homelessness, and chronic disease management. She is committed to serving vulnerable populations and works per diem at Boston Health Care for the Homeless Program; Andrea has also conducted international healthcare work in Haiti. She is a term lecturer and preceptor for nurse practitioner students at the MGH Institute of Health Professions (MGH IHP). Andrea received her Masters of Science in Nursing in 2011 and her Doctorate of Nursing Practice in 2018, both from the MGH IHP. She is board certified in addictions nursing through the Addictions Nursing Certification Board.

Annie Potter, MSN, MPH, NP, CARN-AP

Annie is a Nurse Practitioner at Boston Medical Center and Assistant Professor of Medicine at Boston University School of Medicine. Annie educates and supports health care providers on best practices in the treatment of substance use disorders and serves as the Medical Director for the Massachusetts Office Based Addiction Treatment ECHO. Prior to joining BMC, Annie practiced at a community health center in Baltimore, MD, where she established and served as the clinical lead for the city's first walk-in HIV treatment and prevention program. She is board-certified in addictions and holds specialty certifications for the treatment of HIV and Hepatitis C. Annie earned her Masters of Nursing and Masters of Public Health from the Johns Hopkins School of Nursing and Bloomberg School of Public Health, respectively.

Objectives

The learner will be able to:

• Identify patients appropriate for a trial of buprenorphine treatment. 
• Recognize the benefits of providing low barrier access to care. 
• Discuss the utility of toxicology screening. 
• Describe examples of a harm reduction approach to managing care for persons with opioid use disorder.

Sponsored by

Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Addiction Services

Accreditation information

ACCME Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Boston University School of Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Accreditation/Approval Statement

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Contact Hours: 2.00

Register now